Concepedia

Jennifer Epler

JE

Statistics

Publications

12

Citations

547

H-Index

12

Active since

2000

Affiliations

Health and Functional Exposomics(Current)

University of California, Berkeley

Shanghai Zhangjiang Laboratory

University of Washington

Jennifer Epler is an author at Health and Functional Exposomics specializing in pharmacology, medicinal chemistry, and pharmacy.

Publications per year

2000–2018

12

Publications

12

Design of Selective PAK1 Inhibitor G-5555: Improving Properties by Employing an Unorthodox Low-p <i>K</i> <sub>a</sub> Polar Moiety

Chudi Ndubaku, James J. Crawford, Joy Drobnick et al. · ACS Medicinal Chemistry Letters · 2015 · 86 citations · Full text

, , +10

Phase I study of the checkpoint kinase 1 inhibitor GDC-0575 in combination with gemcitabine in patients with refractory solid tumors

Antoîne Italiano, Jeffrey R. Infante, Geoffrey I. Shapiro et al. · Annals of Oncology · 2018 · 78 citations · Full text

, , +17

Chemically Diverse Group I p21-Activated Kinase (PAK) Inhibitors Impart Acute Cardiovascular Toxicity with a Narrow Therapeutic Window

Joachim Rudolph, Lesley Murray, Chudi Ndubaku et al. · Journal of Medicinal Chemistry · 2016 · 77 citations · Full text

, , +13

Recognition of Breast Cancer Cells by CD8+ Cytotoxic T-Cell Clones Specific for NY-BR-1

Wei Wang, Jennifer Epler, Lupe G. Salazar et al. · Cancer Research · 2006 · 53 citations

, , +17

Discovery and Biological Profiling of Potent and Selective mTOR Inhibitor GDC-0349

Zhonghua Pei, Elizabeth Blackwood, Lichuan Liu et al. · ACS Medicinal Chemistry Letters · 2012 · 46 citations · Full text

, , +17

1–5 of 12